AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) to Present at the Deutsche Bank 2012 dbAccess BioFEST Conference

Published: Nov 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that David Johnston, chief financial officer, is scheduled to present at the Deutsche Bank 2012 dbAccess BioFEST Conference on Monday, December 3, 2012 at 4:35 p.m. (ET) in Boston.

Back to news